LOC729264 Inhibitors
Cycloheximide and rapamycin can lead to reduced synthesis or increased degradation of proteins, respectively, which may affect LOC729264 levels assuming it is a protein that undergoes regular synthesis and degradation cycles. Staurosporine's broad-spectrum kinase inhibition could alter signaling pathways and modify protein functions, affecting LOC729264 if it is phosphorylated as part of its regulation. Actinomycin D and paclitaxel can decrease transcription and disrupt cell division, respectively, which could alter the expression or function of LOC729264 if it is involved in these processes.
Lithium chloride and 2-deoxy-D-glucose modulate signaling pathways and cellular energy metabolism, potentially impacting proteins broadly, including LOC729264. Tunicamycin and MG132 affect protein modification and degradation pathways, which could influence the stability and turnover of LOC729264 if it is subject to these cellular processes. Chloroquine, Brefeldin A, and etoposide affect autophagy, protein trafficking, and DNA damage response, respectively. These processes are critical for maintaining cellular homeostasis, and their disruption could have widespread effects on protein function and levels, including those of LOC729264.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits protein synthesis by interfering with the translocation step in protein synthesis, thus potentially reducing LOC729264 protein levels if produced. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which is involved in protein synthesis and autophagy, possibly affecting LOC729264 protein levels or turnover. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can affect a wide range of signaling pathways, potentially altering the phosphorylation status and activity of LOC729264. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, potentially decreasing LOC729264 mRNA transcription if it is actively transcribed. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Stabilizes microtubules and disrupts cell division, possibly affecting LOC729264 levels if it is involved in cell cycle regulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3 (GSK-3), which could influence multiple signaling pathways and possibly affect LOC729264 activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A glucose analog that inhibits glycolysis, potentially affecting energy metabolism and indirectly influencing LOC729264 function. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, potentially affecting LOC729264 if it undergoes glycosylation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that can lead to the accumulation of misfolded or damaged proteins, possibly affecting LOC729264 stability or turnover. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Lysosomotropic agent that can alter the autophagic process, potentially influencing the degradation of LOC729264 if it is degraded by autophagy. | ||||||